Refractory Cutaneous T-cell Lymphoma

Also known as: Cutaneous T-cell lymphoma refractory / Refractory Cutaneous T-Cell Lymphoma (CTCL)

DrugDrug NameDrug Description
DB00307BexaroteneA retinoid drug used for cutaneous manifestations of T-cell lymphoma in patients who have not responded well to previous systemic therapy.
DB00553MethoxsalenA furocoumarin used to treat psoriasis and vitiligo.
DrugDrug NamePhaseStatusCount
DB12498Mogamulizumab2Active Not Recruiting1
DB00307Bexarotene4Completed1